|
|
The calm after the storm : re-starting ART treatments safely in the wake of the COVID-19 pandemic |
|---|---|
| Author: | The ESHRE COVID-19 Working Group; Gianaroli, Luca1; Ata, Baris2; |
| Organizations: |
1Societa` Italiana Studi di Medicina della Riproduzione, S.I.S.Me.R. Reproductive Medicine Institute, Bologna, Emilia-Romagna, Italy 2Obstetrics and Gynecology Department, Koc University, Istanbul, Turkey 3Reproductive Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
4Fertility Europe Evere, Evere, Belgium
5Department of Obstetrics and Gynaecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland 6Department of Obstetrics and Gynaecology, University of Oulu, Oulu University Hospital and Medical Research Centre, PEDEGO Research Unit, Oulu, Finland 7ESHRE Central Office, Grimbergen, Belgium 8Reproductive Medicine Service, Dexeus Mujer, Hospital Universitari Dexeus/Institut d’Investigacio ́ Biome`dica de Bellvitge, IDIBELL, Barcelona Stem Cell Bank, Regenerative Medicine Programme, Barcelona, Spain 9Rotunda Hospital and Royal College of Surgeons in Ireland, Dublin, Ireland |
| Format: | article |
| Version: | published version |
| Access: | open |
| Online Access: | PDF Full Text (PDF, 0.4 MB) |
| Persistent link: | http://urn.fi/urn:nbn:fi-fe2021070841261 |
| Language: | English |
| Published: |
Oxford University Press,
2021
|
| Publish Date: | 2021-07-08 |
| Description: |
AbstractThe coronavirus disease 2019 (COVID-19) pandemic created a significant impact on medically assisted reproduction (MAR) services. ESHRE decided to mobilize resources in order to collect, analyse, monitor, prepare and disseminate severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) knowledge specifically related to ART and early pregnancy. This article presents the impact of the SARS-CoV-2 pandemic focusing on reproductive healthcare. It details the rationale behind the guidance prepared to support MAR services in organizing and managing the re-start of treatments or in case of any future wave of COVID-19 disease. The guidance includes information on patient selection and informed consent, staff and patient triage and testing, adaptation of ART services, treatment planning and code of conduct. The initiatives detailed in this article are not necessarily COVID-specific and such action plans could be applied effectively to manage similar emergency situations in different areas of medicine, in the future. see all
|
| Series: |
Human reproduction |
| ISSN: | 0268-1161 |
| ISSN-E: | 1460-2350 |
| ISSN-L: | 0268-1161 |
| Volume: | 36 |
| Issue: | 2 |
| Pages: | 275 - 282 |
| DOI: | 10.1093/humrep/deaa285 |
| OADOI: | https://oadoi.org/10.1093/humrep/deaa285 |
| Type of Publication: |
A1 Journal article – refereed |
| Field of Science: |
3121 General medicine, internal medicine and other clinical medicine |
| Subjects: | |
| Copyright information: |
© The Author(s) 2020. Published by Oxford University Press on behalf of European Society of Human Reproduction and Embryology. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
|
https://creativecommons.org/licenses/by-nc/4.0/ |